Abstract
stopped due to fulminant hepatitis. Hepatotoxicity usually occurs in the first month of therapy and mostly Concomitant therapy 8 Chang et al 9 found that moderate transaminases elevation. Schaberg et al
Many studies investigated clinical parameters antituberculosis drugs, but mainly in adult subjects.
of hepatotoxicity due to antituberculosis therapy in children. incidence and characteristics of hepatotoxicity during intended to find the incidence and characteristics children. 
Methods

Results
excluded due to poor adherence to antituberculosis subjects could be analyzed. Most of the subjects (Table 1) ( Table 2) .
of monitoring are presented in Table 3 .
( Table 5) ( 50 (67) 25 (33) 12 (16) 63 (84) 27 (36) 48 (64) 39 (52) 18 (24) 11 (15) 7 (9) OH= other hepatotoxic drugs hepatotoxicity.
